One year ago this April, a new and deadly flu emerged in Mexico that would prove to be one of the most pervasive and virulent influenza strains to emerge in 100 years. As we approach the year anniversary of swine flu entering the public lexicon, join BIOCOM as we hear from influenza experts and discuss lessons learned from this pandemic. How did public health agencies from around the world handle the outbreak? How will vaccine production be handled in the future? And what does the biotech industry need to do better to ensure its ability to respond to public health emergencies like this in the future?

Here KPBS health reporter Tom Fudge asks Brain Plew, Head of Public Health at Life Technologies about what the scientific community has learned about H1N1 over the past year, if the virus has changed and the reason for an actual "flu season". Brian and Tom were joined on the panel by the Vice President of Vaccine Research for Vical Inc., Larry R. Smith, Ph.D, and John D. Tamerius, Ph.D, SVP of Clinical and Regulatory Affairs at Quidel Corporation.

This panel took place on March 17th at the La Jolla Hyatt.